Cite
HARVARD Citation
Angiolillo, A. et al. (2021). Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia: Results From Children's Oncology Group AALL0932. Journal of clinical oncology. 39 (13), pp. 1437-1447. [Online].